We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $7.78B
1-Year Est. Return 45.07%
This Fund
S&P 500
This Quarter Est. Return
+10.13%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$5.12B
AUM Growth
+$288M
Cap. Flow
-$136M
Cap. Flow %
-2.66%
Top 10 Hldgs %
21.33%
Holding
608
New
37
Increased
185
Reduced
325
Closed
15

Top Buys

Rank Stock Value
1
FWM
FAIRWAY GROUP HLDGS CORP CL A COM STK (DE)
FWM
+$26.7M
2
MSGS icon
Madison Square Garden
MSGS
+$11.5M
3
ATML
ATMEL CORP
ATML
+$9.04M
4
CONE
CyrusOne Inc Common Stock
CONE
+$6.61M
5
BRSL
Brightstar Lottery PLC
BRSL
+$6.16M

Top Sells

Rank Stock Value
1
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$90.6M
2
SKS
SAKS INCORPORATED
SKS
+$26.5M
3
BLC
BELO CORP SER A
BLC
+$25.8M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$12.7M
5
LVS icon
Las Vegas Sands
LVS
+$3.93M

Sector Composition

Rank Sector Weight
1 Industrials 16.77%
2 Technology 12.51%
3 Healthcare 12.2%
4 Communication Services 11.01%
5 Consumer Discretionary 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PG icon
51
Procter & Gamble
PG
$340B
$26.3M 0.51%
323,114
-5,570
-2% -$454K
T icon
52
AT&T
T
$164B
$26.3M 0.51%
990,311
+15,542
+2% +$409K
VSH icon
53
Vishay Intertechnology
VSH
$4.6B
$26.3M 0.51%
1,983,351
-49,756
-2% -$631K
MRK icon
54
Merck
MRK
$322B
$26.2M 0.51%
547,983
-32,649
-6% -$1.49M
HLIT icon
55
Harmonic Inc
HLIT
$1.15B
$25.2M 0.49%
3,416,412
-106,706
-3% -$792K
JNS
56
DELISTED
Janus Capital Group Inc
JNS
$25.2M 0.49%
2,035,907
-53,193
-3% -$548K
JPM icon
57
JPMorgan Chase
JPM
$916B
$24.9M 0.49%
426,581
-2,700
-0.6% -$148K
MYGN icon
58
Myriad Genetics
MYGN
$476M
$24.6M 0.48%
1,172,927
-29,900
-2% -$756K
AMCX icon
59
AMC Global Media
AMCX
$450M
$24.4M 0.48%
358,132
-10,464
-3% -$697K
ETN icon
60
Eaton
ETN
$141B
$24.2M 0.47%
318,071
-8,040
-2% -$572K
LAZ icon
61
Lazard
LAZ
$3.96B
$23.4M 0.46%
515,458
-17,025
-3% -$689K
FWM
62
DELISTED
FAIRWAY GROUP HLDGS CORP CL A COM STK (DE)
FWM
$23.1M 0.45%
+1,273,770
New +$26.7M
JNJ icon
63
Johnson & Johnson
JNJ
$640B
$22.5M 0.44%
245,994
+15,326
+7% +$1.41M
SPY icon
64
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$22.5M 0.44%
121,702
+2,565
+2% +$454K
VB icon
65
Vanguard Morningstar Small-Cap ETF
VB
$78.9B
$22.2M 0.43%
201,688
+1,962
+1% +$209K
XOM icon
66
ExxonMobil
XOM
$650B
$22M 0.43%
217,462
+8,097
+4% +$749K
GILD icon
67
Gilead Sciences
GILD
$165B
$21.6M 0.42%
287,189
-3,718
-1% -$259K
CVS icon
68
CVS Health
CVS
$135B
$21.3M 0.42%
297,606
-8,761
-3% -$563K
INXN
69
DELISTED
Interxion Holding N.V.
INXN
$21.1M 0.41%
895,244
+140,190
+19% +$3.17M
HD icon
70
Home Depot
HD
$337B
$20.9M 0.41%
254,282
-15,848
-6% -$1.23M
PFE icon
71
Pfizer
PFE
$143B
$20.5M 0.4%
705,953
-1,908
-0.3% -$55.5K
DD
72
DELISTED
Du Pont De Nemours E I
DD
$20.1M 0.39%
326,231
-2,567
-0.8% -$148K
INTC icon
73
Intel
INTC
$413B
$19.9M 0.39%
768,554
-3,946
-0.5% -$95.5K
SLB icon
74
SLB Ltd
SLB
$72.7B
$19.4M 0.38%
215,552
-4,447
-2% -$402K
FCX icon
75
Freeport-McMoran
FCX
$86.2B
$18.9M 0.37%
499,471
+1,714
+0.3% +$60.8K
1 2
3
4 5

Similar funds

EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $7.73B AUM 14.94% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Pinnacle Associates's Q4 2013 Portfolio in Review

As of Q4 2013, Pinnacle Associates held 608 positions worth $5.12B, up 6% from $4.83B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Pinnacle Associates's Q4 2013 filing shows 37 new, 185 increased, 325 reduced and 15 closed positions. Its largest new stake was FAIRWAY GROUP HLDGS CORP CL A COM STK (DE): 1,273,770 shares worth $23.1M. The largest sale was ONYX PHARMACEUTICALS INC, an estimated $90.6M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Pinnacle Associates's largest Q4 2013 buy was FAIRWAY GROUP HLDGS CORP CL A COM STK (DE): 1,273,770 shares worth $23.1M.
  • Pinnacle Associates added most to Madison Square Garden in Q4 2013, an estimated $11.5M increase.
  • Pinnacle Associates's biggest Q4 2013 reduction was Regeneron Pharmaceuticals, cutting an estimated $12.7M.
  • Pinnacle Associates fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $90.6M.
  • Pinnacle Associates's ten largest holdings make up 21% of its $5.12B portfolio in Q4 2013.
  • Pinnacle Associates opened 37 new positions and closed 15 in Q4 2013.
  • Pinnacle Associates's portfolio value rose 6% quarter-over-quarter to $5.12B.

Based on Pinnacle Associates's 13F filing for Q4 2013, filed 12 Feb 2014.